Picture of Allon Therapeutics logo

NPCUF Allon Therapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Allon Therapeutics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2008
December 31st
2009
December 31st
C2010
December 31st
2011
December 31st
2012
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
CAS
CAS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11.3-7.34-16.1-12.8-14.9
Depreciation
Non-Cash Items0.3710.3580.20.2544.43
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2.05-1.632.270.3490.72
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-12.4-8.07-13.1-11.6-9.27
Capital Expenditures-0.025-0.023-0.013-0.0080
Purchase of Fixed Assets
Other Investing Cash Flow Items1.1200.0380
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities1.09-0.0230.024-0.0080
Financing Cash Flow Items9.42
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities18.409.914.929.52
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7.08-8.09-3.14-6.740.25